Commercialized Micropumps for Drug Delivery

Commercialized Micropumps for Drug Delivery

By Pharma Tech Outlook | Thursday, January 17, 2019

The method of delivery of a drug can have a large impact on its effectiveness. The need for efficient and less side effect drugs to be delivered to patients has led pharmaceutical companies to develop a new drug delivery system.

Various drug delivery companies exist in the healthcare industry today. Gerresheimer is a pharmaceutical plastic and glass packaging company that partners with pharma companies to manufacture high-quality packaging products for drug delivery services. It is headquartered in Düsseldorf, Germany. The company generates revenues of around €1.3 billion with more than 40 plants in Europe, North America, South America, and Asia.

The company's product portfolio includes pharmaceutical packaging and products for the safe and simple administration of medicines. Recently, Gerresheimer acquired Sensile Medical, expanding its business model to become an original equipment manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities. Sensile Medical works closely with pharmaceutical and biotech companies to develop devices to deliver liquid drugs.

On February 6, 2019, Gerresheimer will be showcasing its products at the Pharmapack in Paris with its new subsidiary Sensile Medical AG for the first time.

Chief business officer of Sensile Sandra de Haan says, “Sensile Medical specializes in the development of key technologies for the patient-oriented delivery of liquid drugs.”

Sensile Medical AG has developed a new type of micropump which is an important characteristic of all product platforms. SenseCore is small in dosage and very precise which can be delivered at low cost and consists of only two plastic parts. It has a high degree of flexibility. This is the first micro pump that is used commercially for the treatment of Parkinson’s disease.

Detection of new drug delivery systems and drug delivery carriers could effectively transfer drugs to the site of action in a shorter time, giving maximum therapeutic effect and benefits, as well as improving drug stability and preventing degradation in external environments. Drug delivery technologies improve the absorption, efficiency, and experience of the patient. Improving pharmaceutical formulation’s drug delivery technology can boost its commercial success.

Weekly Brief

New Editions